Projects funded by the NCN
Synthesis and biological evaluation of novel, drug-like multifunctional ligands, as potential anti-Alzheimer's agents targeting cholinesterases and beta-secretase.
2016/21/N/NZ7/03288
Keywords:
β-secretase acetylcholinesterase butyrylcholinesterase Alzheimer Disease organic synthesis inhibition of β-amyloid agregation
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 11 - announced on 2016-03-15
Amount awarded: 49 990 PLN
Project start date (Y-m-d): 2017-04-13
Project end date (Y-m-d): 2018-08-12
Project duration:: 16 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.